U.S. Securities and Exchange Commission
U.S. Securities and Exchange Commission
Rating Score3.3 (4 reviews)
REVIEW THIS COMPANY

U.S. Securities and Exchange Commission News

U.S. Securities and Exchange Commission StreetInsider.com / Apr 28, 2022

Submission to Regulators Globally Is Based on Phase 2/3 Studies of mRNA-1273 in Young Children CAMBRIDGE, MA / ACCESSWIRE / April 28, 2022 / Moderna, Inc. (NASDAQ:MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, today announced that it has submitted a request…

https://investors.modernatx.com/news/news-details/2022/Moderna-Files-for-Authorization-of-Its-COVID-19-Vaccine-in-Young-Children-Six-Months-to-Under-Six-Years-of-Age/default.aspx
Open this page

Moderna

StreetInsider.com

U.S. Securities and Exchange Commission Pfizer: One of the world’s premier biopharmaceutic / Apr 27, 2022

The US Securities and Exchange Commission has accused Chaka Technologies Limited, a digital and broker investment platform of misinforming investors in the United States. The commission in a document on Tuesday, listed Chaka and Citi Investment Capital among 58 unregistered entities using misleading…

https://www.naijanews.com/2022/04/27/popular-nigerian-investment-platform-chaka-accused-of-misinformation-in-us/
Open this page

Popular Nigerian Investment Platform, Chaka Accused Of Misinformation In US

Pfizer: One of the world’s premier biopharmaceutic

U.S. Securities and Exchange Commission Pfizer: One of the world’s premier biopharmaceutic / Apr 27, 2022

Dive in with us as we explore the key catalysts driving sustainable investing into the future. And, most importantly, what these changes mean for you.

https://www.chase.com/personal/investments/learning-and-insights/article/four-reasons-why-sustainable-investing-is-moving-into-the-mainstream
Open this page

Four Reasons Why Sustainable Investing is Moving Into the Mainstream | Chase.com

Pfizer: One of the world’s premier biopharmaceutic

U.S. Securities and Exchange Commission Pfizer: One of the world’s premier biopharmaceutic / Apr 27, 2022

Company delivers record 2021 U.S. GAAP and proforma revenue1 of $738 million and $760 million, respectively2021 Adjusted EBITDA2 margin of 44% -- in line with Company guidanceFinancial results presented in U.S. GAAP CHICAGO, April 27, 2022 (GLOBE NEWSWIRE) -- Verano Holdings Corp. (CSE: VRNO) (OTCQX…

https://finance.yahoo.com/news/verano-announces-2021-fourth-quarter-110000444.html
Open this page

Verano Announces 2021 Fourth Quarter and Full Year U.S. GAAP Financial Results

Pfizer: One of the world’s premier biopharmaceutic

U.S. Securities and Exchange Commission Pfizer: One of the world’s premier biopharmaceutic / Apr 27, 2022

Pfizer Inc. (NYSE: PFE) and Biohaven Pharmaceutical Holding Company Ltd. (NYSE: BHVN) today announced that the European Commission (EC) has granted marketing authorization for VYDURA ® (rimegepant), a calcitonin gene-related peptide (CGRP) receptor antagonist for both the acute treatment of migraine…

https://www.pfizer.com/news/press-release/press-release-detail/pfizer-and-biohavens-vydurar-rimegepant-granted-first-ever
Open this page

Pfizer and Biohaven's VYDURA® (Rimegepant) Granted First Ever Marketing Authorization by European Commission for Both Acute Treatment of Migraine and Prophylaxis of Episodic Migraine

Pfizer: One of the world’s premier biopharmaceutic

U.S. Securities and Exchange Commission GuruFocus.com / Apr 26, 2022

THIS ANNOUNCEMENT IS NOT AN OFFER, WHETHER DIRECTLY OR INDIRECTLY, IN AUSTRALIA, CANADA, HONG KONG, JAPAN, NEW ZEALAND, SOUTH AFRICA OR SWITZERLAND OR IN...

https://www.globenewswire.com/news-release/2022/04/26/2429283/0/en/Prospectus-approved-and-offer-document-published-regarding-NeoGames-S-A-s-recommended-public-offer-to-the-shareholders-of-Aspire-Global-plc.html
Open this page

Prospectus approved and offer document published regarding NeoGames SA's recommended public offer to the shareholders of Aspire Global plc

GuruFocus.com

U.S. Securities and Exchange Commission GuruFocus.com / Apr 26, 2022

MedMen Enterprises Inc. (“MedMen” or the “Company”) (CSE: MMEN) (OTCQX: MMNFF), a premier American cannabis retailer, today announced the partial adjo

https://www.businesswire.com/news/home/20220426005844/en/MedMen-Announces-Partial-Adjournment-of-Annual-and-Special-Meeting-of-Shareholders-until-May-19-2022
Open this page

MedMen Announces Partial Adjournment of Annual and Special Meeting of Shareholders until May 19, 2022

GuruFocus.com

Prev 01 02 03 04 05 Next